Form 4: Vita Coco Director Sells Shares Under 10b5-1 Plan

Vita Coco Company Director Ira Liran sold over 40,000 shares of common stock on November 17, 2025, through a pre-arranged 10b5-1 trading plan.

Summary

• Ira Liran, a Director of Vita Coco Company, Inc. (COCO), reported sales of common stock.
• On November 17, 2025, Mr. Liran directly disposed of 14,619 shares of common stock at a weighted average price of $50.102 per share.
• Also on November 17, 2025, an additional 26,138 shares of common stock were indirectly disposed of by the Ira Liran 2012 Family Trust at a weighted average price of $50.086 per share.
• The total number of shares sold across both direct and indirect transactions was 40,757.
• The sales were executed pursuant to a Rule 10b5-1 trading plan.
• Following these transactions, Mr. Liran directly beneficially owns 523,722 shares and indirectly beneficially owns 636,441 shares through the Ira Liran 2012 Family Trust.
• The prices for the direct sale ranged from $50.00 to $50.47 per share, inclusive.
• The prices for the indirect sale also ranged from $50.00 to $50.47 per share, inclusive.

Sentiment

Score: 5

Explanation: The filing reports an insider sale, which is a neutral event when executed under a pre-arranged 10b5-1 plan, indicating a planned divestment rather than a reaction to new information. It does not inherently suggest positive or negative company performance.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it solely reports past insider transactions.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The indirect sale of 26,138 shares was conducted by the Ira Liran 2012 Family Trust, which is considered a related party to Ira Liran, a Director of the company.

Stakeholder Impact

• Shareholders may observe a director's sale of a significant number of shares, which could be interpreted in various ways. However, the disclosure that the sales were made pursuant to a Rule 10b5-1 trading plan typically mitigates concerns that the sale is based on new, negative material non-public information, suggesting a pre-planned liquidity event.

Key Dates

Recommendation

The sale by a director, while significant in volume, was executed under a pre-arranged Rule 10b5-1 trading plan. This suggests a planned liquidity event rather than a reaction to new material non-public information. Without additional context on the company's performance or other market factors, a 'hold' recommendation is appropriate as this transaction alone does not fundamentally alter the investment thesis.

Keywords

Vita Coco, COCO, Insider Sale, Form 4, Ira Liran, 10b5-1 Plan, Director Transaction, Equity Sale